as 02-21-2025 4:00pm EST
Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue primarily from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.
Founded: | 2000 | Country: | United States |
Employees: | N/A | City: | SEATTLE |
Market Cap: | 2.1B | IPO Year: | 2014 |
Target Price: | $46.60 | AVG Volume (30 days): | 616.9K |
Analyst Decision: | Buy | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.23 | EPS Growth: | N/A |
52 Week Low/High: | $19.69 - $57.90 | Next Earning Date: | 02-19-2025 |
Revenue: | $1,285,684,000 | Revenue Growth: | 15.97% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | 7.49% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
LOW MURRAY B | TRUP | Director | Jan 3 '25 | Sell | $50.00 | 192 | $9,600.00 | 131,321 | |
Qureshi Fawwad | TRUP | Chief Financial Officer | Nov 29 '24 | Sell | $53.08 | 9,867 | $523,788.71 | 0 |
TRUP Breaking Stock News: Dive into TRUP Ticker-Specific Updates for Smart Investing
Zacks
3 days ago
Zacks
3 days ago
Associated Press Finance
3 days ago
MT Newswires
3 days ago
GlobeNewswire
3 days ago
Argus Research
4 days ago
Zacks
10 days ago
Argus Research
18 days ago
The information presented on this page, "TRUP Trupanion Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.